Upper Middle-Income Countries Left Out by New Merck/Ridgeback COVID-19 Antiviral Licensing Deal
Biopharmaceutical Report II Issue25_December 2021 As Merck (NYSE:MRK) and Ridgeback Biotherapeutics sign on to a licensing deal to expand...